Tijana Ignjatovic

Tijana Ignjatovic has a diverse work experience spanning several industries. Tijana started their career as the Founder and Chief Operating Officer of Cambridge Cell Networks in 2001 and held this position until 2005. From 2005 to 2007, they worked as a Postdoctoral Research Associate at the Brain Repair Centre, University of Cambridge. In 2007, they joined Datamonitor Healthcare, Informa Plc as a Senior Analyst, Pharmaceutical Strategy Analysis Team, and later served as a Lead Analyst for Market Access. From 2018 to 2019, they worked as a Senior Director for Trends and Market Access at the same company. Most recently, Tijana has been working at Market Access Transformation since 2019, where they held roles as a Senior Consultant, Associate Director, and currently serves as the Director Ops and New Product Development Lead.

Tijana Ignjatovic completed their education with a National Baccalaureate from Peta Beogradska Gimnazija in 1995. Tijana then pursued a Bachelor of Arts degree in Natural Sciences, specializing in Biochemistry, from Trinity College at the University of Cambridge from 1996 to 1999. Tijana furthered their studies at the University of Cambridge's MRC-LMB, where they obtained their PhD in Biochemistry and Structural Biology from 1999 to 2003. Later, they pursued a Postgraduate Certificate in International HTA module of MSc in HTA, Pricing and Reimbursement at ScHARR, University of Sheffield, which they completed from 2013 to 2016.